Reopening will not be easy, but it can be done
The pain from the COVID-19 pandemic will be here for a while, but we can learn from it. That was a theme of a UC Santa Barbara economic webinar examining the effects of COVID-19 on Santa Barbara County and what that means going forward. The May 7 webinar featured four local experts on subjects ranging Read More →
CSU cancels in-person classes for fall
The California State University system, including Cal Poly San Luis Obispo and CSU Channel Islands, will cancel nearly all in-person classes in the fall and provide instruction online due to the COVID-19 pandemic, Chancellor Timothy White announced May 12. “Our university, when open without restrictions and fully in person, as is the traditional norm of Read More →
Sientra misses earnings estimates as net loss grows
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county stocks mixed but most biotechs gain
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-Counties start to reopen closed parts of the region’s economy
California is reopening some previously-closed establishments, but what that actually looks like will depend on the county — and in some places, the city — where people live. San Luis Obispo, Santa Barbara and Ventura counties are all taking different approaches as they figure out how to best protect their populations while allowing some parts Read More →
Amgen’s Otezla could be treatment for COVID-19
Amgen’s newly acquired Otezla product line could find a role in a suite of new therapies designed to treat COVID-19 patients. News of the potential for the rheumatoid arthritis product came as the Thousand Oaks-based biotech reported that earnings and revenue shot up in the first quarter. The company’s outlook stayed flat as it shifts Read More →
MannKind beats earnings estimates
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
